Table of Contents
A breast cancer diagnosis changes everything in an instant. The uncertainty, the fear, and the idea of facing invasive surgeries with long recoveries can feel overwhelming. Yet, complementary and alternative medicine keeps opening new doors—offering safe, less invasive ways to heal that genuinely honor your body and restore your peace of mind.
The FDA has approved IceCure Medical’s ProSense® Cryoablation System for low-risk breast cancer in women 70 and older. This minimally invasive procedure offers a gentler, effective treatment option, empowering women with more choices for their care and healing journey.
In this post, we will explore exactly what this FDA authorization means for breast cancer care. You will learn how the ProSense system works, review the impressive data behind the approval, and hear real stories from women who chose this empowering treatment.
A Giant Leap for Minimally Invasive Care
For decades, the standard treatment for early-stage breast cancer involved lumpectomies or mastectomies. These surgeries also removed healthy breast tissue, require significant recovery time, and often demand additional post surgery long-term therapies. Surgeries leave both emotional and physical scars, heavily impacting a woman’s body image.
The FDA authorization of Cryoablation shifts the entire landscape of care. This approval targets women aged 70 and older with early-stage, low-risk breast cancer who take adjuvant endocrine therapy. It gives thousands of women the power to freeze their tumors away without stepping foot in an operating room.
Instead, it offers an outpatient procedure that destroys tumors simply by freezing them. You keep your breast tissue. You skip the general anesthesia. You go home the very same day.
This breakthrough directly impacts an estimated 46,000 women each year in the United States. It provides a highly effective alternative for patients who want to avoid surgery or those who might not be ideal surgical candidates. By authorizing ProSense, the FDA recognizes that treating cancer should not always require removing parts of the female body.
What Is Cryoablation?
Cryoablation sounds like science fiction, but the reality is beautifully simple. The procedure harnesses the extreme cold of liquid nitrogen to destroy cancerous cells. Your doctor starts by numbing your breast with local anesthesia. You stay completely awake and comfortable. Using real-time ultrasound imaging, the doctor guides a small, thin hollow needle—called a cryoprobe—directly into the center of the breast tumor.
Once the probe is perfectly positioned, the system pumps liquid nitrogen into the needle. The temperature drops dramatically to -170 degrees Celsius. This intense cold creates a targeted ice ball that engulfs the tumor and a small margin of surrounding tissue. The freezing process completely destroys the cancer cells.
Over time, your body naturally reabsorbs the destroyed tissue, leaving the healthy tissue unharmed.
How is this different than Cryotherapy?
You may hear the term “cryotherapy” in this context, but do not confuse it with the cryotherapy you receive in local spas. For whole-body spa cryotherapy, individuals stand in a chamber where their body is exposed to extremely cold air for a few minutes to reduce inflammation.
While spa cryotherapy focuses on general wellness, cryoablation is a precise, medical procedure and should be performed by a licensed medical professional to eradicate cancer.
The Core Benefits of Cryoablation
Keep Your Natural Shape
One of the most significant benefits of cryoablation involves cosmetics and body preservation. Because no tissue gets surgically removed, your breast maintains its natural shape and volume.
The tiny needle leaves virtually no scar. You will not need cosmetic follow-up procedures or breast reconstruction. You can look in the mirror and recognize your own body, completely intact and whole.
Fast and Easy Recovery
Surgery demands weeks of rest, physical limitations, and careful wound management. Cryoablation flips that narrative entirely.
The entire procedure takes just about an hour or so in a doctor’s office. You bypass the hospital waiting rooms and the overnight stays. The extreme cold actually acts as a natural numbing agent, significantly reducing post-procedure pain.
Most patients return to their normal daily activities within 24 hours. The median recovery time sits at just one single day. You can get back to your family, your hobbies, and your life almost immediately.
The Science That Earned FDA Trust
IceCure Medical earned FDA authorization through its landmark ICE3 clinical trial, the largest study ever for liquid nitrogen-based cryoablation of breast tumors. The trial tracked 194 women with low-risk, early-stage breast cancer who chose cryoablation over surgery.
The results were compelling: a local recurrence rate of just 3.1% within five years, mirroring the success of traditional lumpectomies. This proves that a gentler approach doesn’t compromise safety or effectiveness. Additionally, side effects were minimal and temporary, with no lasting negative effects.
Real Women, Real Results
Numbers and clinical trials matter, but the true impact of this technology lives in the stories of the women who experience it. During the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee Review November 7, 2024, the voices of real patients painted a vivid picture of why choices matter.
Muriel bravely shared her positive experience with cryoablation. She faced her diagnosis with understandable fear, worrying about the physical toll of traditional surgery. Choosing cryoablation gave her a sense of profound relief. She described the procedure as incredibly manageable, allowing her to heal quickly without the trauma of losing part of her breast. Her story highlights the immense emotional comfort that comes from preserving your body.
Susan took the floor to passionately advocate for diverse treatment options. She emphasized that no two women are the same, and neither are their cancer journeys. Having a non-surgical option like ProSense gives women the agency to choose a path that aligns with their personal values and health goals. Susan’s advocacy underscores a crucial point: empowering patients means giving them safe, effective alternatives to the operating table.
Pam, a participant in the ICE3 trial, echoed these sentiments perfectly. She noted the incredible relief of skipping cosmetic follow-ups and avoiding scars. “There was no pain,” she explained, calling it one of the easiest things she had ever done. She left the clinic with no memory of any limits on her physical activity, grateful to still have her breast completely intact.
These women represent thousands more who will now have the chance to freeze their cancer and keep their bodies whole.
Looking Ahead: The Post-Market Study
While the FDA has officially granted marketing authorization, the work to improve breast cancer care continues. As part of the authorization, the FDA requested a post-market surveillance study.
IceCure Medical will conduct this new study with approximately 400 patients across 30 different clinical sites. This effort will gather even more data on how ProSense performs in real-world settings over time.
This ongoing research ensures that the medical community can continue fine-tuning the treatment. It also guarantees that future patients will benefit from an ever-growing pool of safety and efficacy data. Doctors will have even more confidence when recommending cryoablation as a first-line defense against low-risk tumors.
Empowering Your Breast Cancer Care Choices
The FDA authorization of the ProSense Cryoablation System is a beautiful milestone, but it is really just the beginning. It is still not available for many women who could use this procedure at early ages of diagnosis. It leaves much room for improvement regarding accessibility for all women.
This approval is a step forward, but it raises important questions about equity in healthcare. We must ask: why has Medicare approved and paid for cryoablation for men’s prostate cancer treatment since 1999? Why are women just now, 26 years later, getting very controlled criteria options for women with a breast cancer diagnosis? Advocacy is key to ensuring all women have access to life-changing treatments like ProSense.
While there are still some significant barriers for women, this is a powerful new tool for those that meet the criteria. Remember girls, you always have the right to ask your doctor about minimally invasive options. If they don’t know it, do your research, reach out to us at Sangha Healing. You have the right to protect your healthy tissue and demand treatments that respect your quality of life.
Healing from cancer should not mean sacrificing your comfort or your physical identity. Talk to your healthcare provider about ProSense cryoablation. Ask if freezing your tumor makes sense for your specific diagnosis.
For more on accessibility to Cryoablation for women, read our dedicated post: Cryotherapy for Breast Cancer, What You Need to Know.
Medicine is evolving, and so are your options. Take charge of your health journey, ask questions, and demand treatments that align with your values. The power to choose is yours.
